Hinge Health launches comprehensive Migraine Care Program

Hinge Health (NYSE: HNGE) launched a Migraine Care Program, combining its FDA-cleared Enso® wearable for rapid, drug-free migraine relief with AI-powered trigger tracking, exercise therapy, and expert-led prevention.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• Cleared by the FDA for migraine, Hinge Health’s Enso® delivers on-demand pain relief
• Already 125+ clients covering more than two million people have adopted the Migraine Care Program

SAN FRANCISCO--(BUSINESS WIRE)-- Hinge Health, Inc. (NYSE: HNGE) today introduced its Migraine Care Program, offering rapid drug-free pain relief, personalized trigger management, and expert-led prevention for members. With meaningful overlap between the treatments and clinical best practices for migraine and musculoskeletal (MSK) care, Hinge Health is leveraging its proven expertise in nerve stimulation, exercise therapy, and behavior change to deliver comprehensive, whole-person care for people living with migraine, MSK pain, or both.

Migraine affects one in six Americans, with double the prevalence for women versus men¹. Approximately 75% of those who suffer from migraine pain also have MSK pain² and the personal and financial burden is significant. People with migraine drive more than $16,000 in annual medical and pharmaceutical spend – over twice as much as those without migraine³. Nationally, migraine costs U.S. businesses an estimated $78 billion each year⁴, and drives absenteeism and reduced productivity.

“Migraine is one of the most disabling and widespread neurologic conditions, yet existing treatment options are insufficient,” said Dr. Jeffrey Krauss, MD, Chief Medical Officer of Hinge Health. “The FDA recently cleared our proprietary Enso device for the treatment of migraine, enabling us to deliver a first-of-its-kind care solution that combines groundbreaking technology with a full care team.”

The Hinge Health migraine care program will offer:

• Rapid, drug-free pain relief: Hinge Health's FDA-cleared Enso, a specialized wearable device designed for pain relief, now reduces migraine pain in minutes.
• Personalized trigger tracking & insights: AI-powered insights help members identify and manage migraine triggers across environmental, lifestyle, and dietary factors.
• Proactive prevention: Exercise therapy and lifestyle guidance led by expert care teams reduce the frequency and severity of migraine attacks, stopping the pain before it starts.

To date, more than 125 clients covering more than two million people have adopted the Hinge Health Migraine Care Program, signaling that employers are ready to act on one of the leading causes of disability for people under 50 years of age⁵.

“We’re excited to introduce this Migraine Care Program especially because our employees consistently share positive experiences with Hinge Health’s offerings,” says Rachel Harrell, Manager of Benefits Strategy for Sodexo, a food and facilities management company. “We’re committed to expanding benefits that truly make a difference."

The Migraine Care Program will roll out in May 2026. Learn more here.

About Hinge Health

Hinge Health is focused on scaling and automating the delivery of health care. Leveraging an AI-powered care model, wearable devices, and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that improves member outcomes and experiences, while reducing costs for clients. The company is headquartered in San Francisco, California.

References

1. The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies
2. Prevalence of neck pain in migraine and tension-type headache: a population study
3. Hinge Health analysis of Merative MarketScan® Commercial Claims and Encounters Database (2023)
4. The burden of neurological disease in the United States: a summary report and call to action
5. Migraine is first cause of disability in under 50s: will health politicians now take notice?

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20260429087251/en/

Media Contact: media@hingehealth.com

Source: Hinge Health, Inc.

Key Terms

fda regulatory

The FDA is the U.S. federal agency that evaluates and approves medical drugs, devices, biological therapies and certain foods; think of it as the gatekeeper that decides whether a medical product is safe and effective for patients. For investors, FDA decisions determine whether a company can sell a product, affect expected revenue and introduce regulatory risk, so approvals, rejections or safety warnings can quickly move a company's valuation and stock price.

enso technical

ENSO (El Niño–Southern Oscillation) is a recurring climate pattern involving warming (El Niño) or cooling (La Niña) of the tropical Pacific Ocean that shifts global weather. For investors it matters because those weather swings are like a giant thermostat that alters crop yields, energy demand, shipping conditions and insurance losses, which can move commodity prices, corporate earnings and sector performance across markets.

msk medical

msk is short for musculoskeletal, the body system made up of bones, muscles, joints and connective tissues that allow movement and support. Investors watch msk developments because treatments, devices and surgeries for injuries or chronic conditions drive demand, regulatory reviews and clinical trial outcomes—much like how a car’s suspension system determines ride quality, the health of the musculoskeletal system affects healthcare spending and revenue potential for related companies.

ai-powered technical

"AI-powered" describes technology that uses artificial intelligence to perform tasks, make decisions, or analyze information automatically. It’s similar to having a highly skilled assistant that can learn from data, recognize patterns, and improve over time, helping to make processes faster and more accurate. For investors, this means better insights and more efficient operations, potentially leading to smarter investment choices.

wearable device technical

A wearable device is a small electronic gadget you wear on your body—like a watch, patch, or smart clothing—that continuously collects health, activity or biometric data and usually connects to a phone or cloud. For investors it matters because these devices can create steady services revenue, valuable real‑time data, and new medical or consumer applications; think of them as continuous sensors that give companies a direct window into user behavior and health trends.